Pharmacie Nationale D'approvisionne Pharmaceutical Import Profile — Senegal (DGFT 2022–2026)

Name: Pharmacie Nationale D'approvisionne Pharmaceutical Import Records from India — 2 Products, $130.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharmacie Nationale D'approvisionne — Pharmaceutical Importer Profile (2026) | 2 Products, $130.2K Trade | TransData Nexus

Pharmacie Nationale D'approvisionne

Pharmaceutical Importer · Senegal · Advanced Oncology Focus · $130.2K Total Trade · DGFT Verified

Pharmacie Nationale D'approvisionne is a pharmaceutical importer based in Senegal with a total trade value of $130.2K across 2 products in 1 therapeutic categories. Based on 6 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Pharmacie Nationale D'approvisionne sources from 6 verified Indian suppliers, with United Biotech Private Limited accounting for 58.5% of imports.

Pharmacie Nationale D'approvisionne — Import Portfolio & Supplier Network

Pharmacie Nationale D'approvisionne import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Pharmacie Nationale D'approvisionne?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
United Biotech Private Limited	$836.1K	64	58.5%
Florencia Healthcare	$266.5K	10	18.6%
Unijules Life Sciences Limited	$164.4K	5

What Formulations Does Pharmacie Nationale D'approvisionne Import?

Formulation	Value	Ships
Pharma product-capiflo(capecitabine	$100.0K	2
Pharma : 2 fdc tablets (150/75) paho	$50.0K	1
Pharma product-graniflo 3(granisetron	$50.0K	1
Paclitec 100 (paclitaxel injection ip100mg)b/n:ptie4b1mfg	$50.0K	1
Iohexo-m 300 (lohexol lnjection USP 300mgl/ML)batch no:2439m2401,m-12/2024	$50.0K	1
Iohexo-m 350 (lohexol lnjection USP 350mgl/ML)batch no:2342m2401,m-12/2024,e-11/2027=1000 b. no:2342a2501,m-01/2025	$49.7K	1
Unicarb 450 MG INJ,carboplatin for	$49.1K	1
Unicarb 450 MG INJ carboplatin for	$47.0K	1
Vinotec 50 (vinorelbine injection IP 50MG/5ML) , b/n:vnic5b2,md:03/2025	$42.8K	1
(other medicaments-erythropoietin) erythropoietin injection repoitin 5000 IU (recombinant products)	$39.7K	1
Paclitec 100 ,paclitaxel INJ USP 100MG	$38.3K	1
Paclitec 100 (paclitaxel injection USP 100MG/16.66ML)	$37.3K	1
Noralin INJ noradrenlaine INJ 2MG/2ML	$36.8K	1
Pharma product-doce-fh 80(docetaxel	$36.1K	1
Pharmaceutical products: lefer syrup 125ML (ferric ammonium citrate syrup) (Pack : 125 ML)	$36.0K	2

Pharmacie Nationale D'approvisionne imports 82 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Vinorelbine	Advanced Oncology	$71.6K	2	2.1%	12
2	Thalidomide	Advanced Oncology	$58.5K	4	3.0%	9

Pharmacie Nationale D'approvisionne imports 2 pharmaceutical products across 1 categories into Senegal totaling $130.2K.

Pharmacie Nationale D'approvisionne — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharmacie Nationale d'Approvisionnement (PNA) is a government-owned public health establishment in Senegal, established in 1954 to meet the medical and pharmaceutical needs of French West Africa. Following Senegal's independence, PNA became a public service under the Ministry of Health by Ministerial Order 75-49 of 12 May 1975. Its legal existence was further solidified by Decree 79-416 of 14 May 1979. PNA operates with administrative and financial autonomy, functioning as a non-hospital public health establishment under the technical supervision of the Ministry of Health and Social Action.

Headquartered in Dakar, PNA's primary mission is to ensure the financial and geographical accessibility of essential medicines and health products to the Senegalese population. This involves the procurement, storage, and distribution of medications to public health facilities across the country. PNA is organized into regional supply pharmacies (PRA) in various regions, including Dakar, Diourbel, Fatick, Kaolack, Kolda, Louga, Matam, Saint-Louis, Tambacounda, Thies, and Ziguinchor, facilitating efficient distribution to even the most remote areas.

2Distribution Network

PNA's distribution network is centralized at its main warehouse in Dakar, which houses the reception area, storage facilities—including five cold storage rooms for vaccines and other temperature-sensitive products—and a transfer zone. This central facility serves as the hub for distributing approximately 964 products, including 282 medications for health centers, 118 for health posts, and 52 for health huts.

To enhance its reach, PNA operates additional warehouses in other locations, addressing space constraints and ensuring timely delivery. The distribution process is organized based on a monthly delivery plan, tailored to the needs of each regional supply pharmacy. Notably, deliveries can be completed within 24 hours to regions as distant as Tambacounda, located 452 km east of Dakar.

3Industry Role

As the primary wholesaler and distributor of essential medicines in Senegal, PNA plays a pivotal role in the country's pharmaceutical supply chain. It is responsible for the procurement, storage, and distribution of medications to public health facilities, ensuring that essential health products are accessible to the entire population. PNA's operations are guided by the National List of Essential Medicines and Health Products, which is regularly updated to reflect the country's health priorities. (files.clisp.fr)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pharmacie Nationale D'approvisionne

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

PNA's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. Between 2022 and 2026, PNA imported a total of $130,000 worth of finished pharmaceutical formulations from India, comprising six shipments. The top two products imported were Vinorelbine ($72,000) and Thalidomide ($59,000), accounting for 2.1% and 3.0% of the total import value, respectively. These imports were sourced from six unique Indian suppliers, with United Biotech Private Limited being the largest contributor, supplying $836,000 worth of products across 64 shipments.

This sourcing pattern indicates a strategic choice by PNA to leverage India's competitive pricing and manufacturing capabilities. However, the concentration on a limited number of suppliers and products may pose risks related to supply chain disruptions or regulatory changes affecting these suppliers. The stability of these relationships is crucial for maintaining a consistent supply of essential medicines.

2Supply Chain Resilience

PNA's reliance on a concentrated group of Indian suppliers for its pharmaceutical imports suggests a need for enhanced supply chain resilience. The limited number of suppliers increases vulnerability to potential disruptions, such as production issues, regulatory changes, or geopolitical tensions affecting trade routes. Diversifying the supplier base and incorporating a broader range of formulations could mitigate these risks. Additionally, establishing backup suppliers and developing contingency plans are essential strategies to ensure uninterrupted access to critical medications.

Importing Pharmaceuticals into Senegal — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Senegal

1Regulatory Authority & Framework

In Senegal, the National Regulatory Authority of Medicines and Health Products (ANAM) is responsible for overseeing the regulation and control of pharmaceutical products. ANAM ensures that all imported medicines meet the required safety, efficacy, and quality standards. The regulatory framework governing pharmaceutical imports includes compliance with the National List of Essential Medicines and Health Products, which is regularly updated to reflect the country's health priorities. (files.clisp.fr)

2Import Licensing & GMP

Importers of pharmaceutical products into Senegal must obtain the necessary import licenses and ensure that their products comply with Good Manufacturing Practice (GMP) standards. Senegal recognizes GMP certifications from reputable bodies, including the World Health Organization (WHO) and the European Union (EU). Importers are required to provide documentation such as certificates of origin, commercial invoices, and packing lists. Additionally, a Certificate of Conformity issued by the Senegalese Bureau of Standards (ASN) may be required for certain products.

3Quality & Labeling

Pharmacie Nationale D'approvisionne — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

PNA's focus on importing advanced oncology medications, specifically Vinorelbine and Thalidomide, indicates a strategic alignment with the country's healthcare priorities. The demand for these products is driven by the prevalence of cancer and the need for effective treatment options. By sourcing these medications from India, PNA aims to provide affordable and accessible treatment options to the Senegalese population, addressing a critical gap in the healthcare system.

2Sourcing Profile

PNA's sourcing strategy emphasizes the procurement of generic drugs, particularly in the oncology therapeutic category. The preference for finished pharmaceutical formulations over raw active pharmaceutical ingredients (APIs) suggests a focus on ready-to-use products that can be directly distributed to healthcare facilities. India's robust pharmaceutical manufacturing sector, known for producing high-quality generics, aligns well with PNA's procurement needs, ensuring a consistent supply of essential medications.

3Market Positioning

Based on its product mix, PNA primarily serves the public healthcare sector in Senegal, supplying essential medications to hospitals, health centers, and other public health facilities. The focus on advanced oncology medications positions PNA to address the needs of cancer patients within the public healthcare system, ensuring that these critical treatments are accessible and affordable.

Seller's Guide — How to Become a Supplier to Pharmacie Nationale D'approvisionne

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with PNA, particularly those offering a diverse range of high-quality, WHO-GMP-compliant products. Gaps in PNA's current sourcing include a limited supplier base and a narrow product focus. By expanding its supplier network and product offerings, PNA can enhance the resilience of its supply chain and better meet the evolving healthcare needs of the Senegalese population.

2Requirements & Qualifications

Indian exporters seeking to supply PNA must ensure that their products comply with Senegal's regulatory requirements, including obtaining the necessary import licenses and providing documentation such as certificates of origin, commercial invoices, and packing lists. Products must adhere to GMP standards recognized by WHO or the EU, and labeling must be in French, containing all required information. Additionally, a Certificate of Conformity from the Senegalese Bureau of Standards (ASN) may be required for certain products.

3How to Approach

Frequently Asked Questions — Pharmacie Nationale D'approvisionne

What products does Pharmacie Nationale D'approvisionne import from India?

Pharmacie Nationale D'approvisionne imports 2 pharmaceutical products across 1 categories. Top imports: Vinorelbine ($71.6K), Thalidomide ($58.5K).

Who supplies pharmaceuticals to Pharmacie Nationale D'approvisionne from India?

Pharmacie Nationale D'approvisionne sources from 6 verified Indian suppliers. The primary supplier is United Biotech Private Limited (58.5% of imports, $836.1K).

What is Pharmacie Nationale D'approvisionne's total pharmaceutical import value?

Pharmacie Nationale D'approvisionne's total pharmaceutical import value from India is $130.2K, based on 6 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pharmacie Nationale D'approvisionne focus on?

Pharmacie Nationale D'approvisionne imports across 1 categories. The largest: Advanced Oncology (100.0%).

Get Full Pharmacie Nationale D'approvisionne Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.